Document is current
Any future updates will be listed below
-
Authors
Krohn-Grimberghe, Marvin
Mitchell, Michael J. https://orcid.org/0000-0002-3628-2244
Schloss, Maximilian J.
Khan, Omar F. https://orcid.org/0000-0003-3811-2369
Courties, Gabriel
Guimaraes, Pedro P. G.
Rohde, David
Cremer, Sebastian
Kowalski, Piotr S. https://orcid.org/0000-0001-8607-0189
Sun, Yuan
Tan, Mingchee
Webster, Jamie
Wang, Karin https://orcid.org/0000-0001-7812-2583
Iwamoto, Yoshiko
Schmidt, Stephen P.
Wojtkiewicz, Gregory R. https://orcid.org/0000-0002-3148-8411
Nayar, Ribhu
Frodermann, Vanessa https://orcid.org/0000-0001-5566-6692
Hulsmans, Maarten https://orcid.org/0000-0003-1009-658X
Chung, Amanda
Hoyer, Friedrich Felix
Swirski, Filip K. https://orcid.org/0000-0002-3163-9152
Langer, Robert https://orcid.org/0000-0003-4255-0492
Anderson, Daniel G. https://orcid.org/0000-0001-5629-4798
Nahrendorf, Matthias https://orcid.org/0000-0002-4021-1887
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (HL125428)
U.S. Department of Health & Human Services | NIH | Center for Information Technology (HL125428)
- License Information
-
More Information
Article History
Received: 9 August 2018
Accepted: 3 September 2020
First Online: 5 October 2020
Competing interests
: R.L. has served as an advisor to Alnylam Pharmaceuticals. For a list of entities with which R.L. is involved, compensated or uncompensated, see . M.N. has received consulting fees unrelated to this work from Verseau, Gimv and IMF Therapeutics. The remaining authors declare no competing interests.
